International

Flora Growth Appoints Sammy Dorf, Verano Co-Founder, as Executive Chairman

Adds Verano Co-Founder to its Board as it Accelerates its Entry into the THC-Infused Beverage Market

Flora Growth Enters Supply Agreement With Curaleaf Targeting $450 Million German Cannabis Market

The agreement will facilitate the importation of high-quality medical cannabis products into Germany

Curaleaf Denies Having Supply Agreement With Flora Growth for German Market

Florida-based Flora Growth issued a press release indicating it partnered with Curaleaf to bring medical cannabis products to the European market.

Puro Announces Strategic Investment from Te Rūnanga o Kaikōura

The partnership will create employment opportunities and enhance community well-being.

Curaleaf Issues Report on Illicit Online Cannabis Sales, Urges UK Government Action

The international cannabis company’s report reveals serious health risks of mold, lead and synthetic cannabinoids in unregulated cannabis.

MedCana Subsidiary in Colombia Enters Negotiations With Australian Firm for Pharma Cannabis Supply

The company is poised to enter into a supply agreement with $1.2 million to $2.4 million annually.

Aurora Introduces Innovative Cannabis Oil Range in Australia

The Canadian cannabis company and MedReleaf Australia launched the oil products to offer enhanced patient car options.

Premier Graphene’s Affiliate Advancing Industrial Hemp Initiatives in Mexico

The California-based company’s business partner, HGI Industrial Technologies, executed a joint venture with Santa Rosa Green Seeds.

Tilray Medical Launches Redecan Cannabis Brand in Australia

The company’s EU-GMP-certified medical cannabis products are now available in Australia with a prescription.

Curaleaf Reports $342 Million in Q2 Revenue

The global cannabis company now operates in 15 countries.

Tilray’s Aphria RX Receives Cannabis Trading License in Germany

The license significantly expands the company’s commercial growth opportunities.

Tilray Receives 1st Cannabis Cultivation License in Germany Under New Regulations

The company’s Aphria RX facility will experience a five-fold increase in product and cultivate 31 strains to enhance patient access across the country.

Page 1 of 62

Next Page